PMDA — authorised 27 September 2021
- Marketing authorisation holder: OTSUKA PHARMACEUTICAL Co., Ltd
- Status: approved
🇯🇵 Moizerto in Japan
PMDA authorised Moizerto on 27 September 2021
Marketing authorisations
PMDA
- Application: Moizerto
- Local brand name: Moizerto
- Status: approved
Moizerto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Moizerto approved in Japan?
Yes. PMDA authorised it on 27 September 2021; PMDA has authorised it.
Who is the marketing authorisation holder for Moizerto in Japan?
OTSUKA PHARMACEUTICAL Co., Ltd holds the Japanese marketing authorisation.